36875-26-0

Basic information

• Product Name: N-TRIFLUOROACETYL-D-GLUCOSAMINE
• Synonyms: 2-DEOXY-2-TRIFLUOROACETAMIDO-D-GLUCOPYRANOSE;2-DEOXY-2-TRIFLUOROACETAMIDO-D-GLUCOSE;N-TRIFLUOROACETYL-D-GLUCOSAMINE;trifluoroacetylglucosamine;2-Deoxy-2-trifluoroacetamido-D-glucose ,96%;N-Trifluoroacetyl-D-glucosamine;2,2,2-Trifluoro-N-((2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)acetamide
• CAS NO: 36875-26-0
• Molecular Formula: C8H12F3NO6
• Molecular Weight: 275.18
• Product Categories: 13C & 2H Sugars;Aminosugars;Biochemistry;Glucose;Sugars;aldehydes;Carbohydrates & Derivatives
• Mol File: 36875-26-0.mol
• Article Data: 1

Chemical Properties

• Melting Point: 182°C
• Boiling Point: 514.6°Cat760mmHg
• Flash Point: 265°C
• Appearance: /
• Density: 1.69g/cm³
• Storage Temp.: Hygroscopic, Refrigerator, Under Inert Atmosphere
• Solubility: Methanol (Slightly), Water (Sparingly)
• Stability: Hygroscopic
• CAS DataBase Reference: N-TRIFLUOROACETYL-D-GLUCOSAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-TRIFLUOROACETYL-D-GLUCOSAMINE(36875-26-0)
• EPA Substance Registry System: N-TRIFLUOROACETYL-D-GLUCOSAMINE(36875-26-0)

Safety Data

• Hazardous Substances Data: 36875-26-0(Hazardous Substances Data)

Usage

Chemical Properties

Off White-Yellow Crystalline Solid

Uses

2-Deoxy-2-trifluoroacetamido-D-glucose (cas# 36875-26-0) is a compound useful in organic synthesis.

Upstream product

• 383-63-1 ethyl trifluoroacetate, 
• 66-84-2 D-(+)-glucosamine hydrochloride 

Relevant articles and documents

Lipid A analogs having immunoactivating and anti-tumor activity

Compounds of formula (I): STR1 in which: R1 is hydroxy, protected hydroxy, fluorine, or --OP(O)(OH)2 ; R2 and R3 are independently optionally substituted C6 -C20 aliphatic acyl; R4 is hydroxy, protected hydroxy, or --OP(O)(OH)2, where at least one of R1 and R4 is --OP(O)(OH)2 ; and R5 is hydroxy, protected hydroxy, or fluorine; provided that, except where at least one of R1 and R5 is fluorine, then at least one of R2 and R3 is a substituted C6 -C20 aliphatic acyl having (i) at least one halogen substituent and (ii) at least one substituent selected from the group consisting of halogen, hydroxy and C6 -C20 aliphatic acyloxy or at least one of R2 and R3 is a substituted C6 -C20 aliphatic acyl which is substituted by at least one halogen-substituted C6 -C20 aliphatic carboxylic acyloxy; have Lipid A-like activity and may be used for the treatment, prophylaxis, diagnosis and support of an animal suffering a disease or disorder arising from a deficiency in the immune system or from a tumor. They may be prepared by phosphorylation of corresponding compounds lacking a phosphoryl group.